Healthcare provider profile · identity verified

Julio E. Geraldino, MD

Internal Medicine · YAUCO, PR · NPI 1891738563

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Famotidine	Famotidine	251	50
Losartan Potassium	Losartan Potassium	246	47
Simvastatin	Simvastatin	209	49
Levothyroxine Sodium	Levothyroxine Sodium	194	36
Metformin Hcl	Metformin Hcl	181	36
Ezetimibe	Ezetimibe	170	35
Atorvastatin Calcium	Atorvastatin Calcium	163	41
Glimepiride	Glimepiride	155	29
Pantoprazole Sodium	Pantoprazole Sodium	155	35
Gabapentin	Gabapentin	150	35
Amlodipine Besylate	Amlodipine Besylate	145	31
Metoprolol Succinate	Metoprolol Succinate	136	25
Lisinopril	Lisinopril	133	32
Synthroid	Levothyroxine Sodium	119	16
Montelukast Sodium	Montelukast Sodium	107	19
Hydrochlorothiazide	Hydrochlorothiazide	92	17
Alendronate Sodium	Alendronate Sodium	91	17
Clopidogrel	Clopidogrel Bisulfate	77	18
Donepezil Hcl	Donepezil Hcl	64	12
Enalapril Maleate	Enalapril Maleate	63	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	60	14
Carvedilol	Carvedilol	58	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	56	suppressed
Furosemide	Furosemide	53	13
Memantine Hcl	Memantine Hcl	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	50	12
Farxiga	Dapagliflozin Propanediol	49	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	49	12
Omeprazole	Omeprazole	44	suppressed
Pravastatin Sodium	Pravastatin Sodium	44	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	37	suppressed
Sertraline Hcl	Sertraline Hcl	34	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	suppressed
Atenolol	Atenolol	28	suppressed
Rivastigmine	Rivastigmine	28	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Humalog	Insulin Lispro	23	suppressed
Azithromycin	Azithromycin	22	21
Nifedipine Er	Nifedipine	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	16
Theophylline Er	Theophylline Anhydrous	21	suppressed
Levofloxacin	Levofloxacin	19	16
Trueplus Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Indapamide	Indapamide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Finasteride	Finasteride	16	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Eliquis	Apixaban	14	suppressed
Flecainide Acetate	Flecainide Acetate	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Selegiline Hcl	Selegiline Hcl	12	suppressed
Sure Comfort	Syringe And Needle,insulin,1ml	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Cefadroxil	Cefadroxil	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Levemir	Insulin Detemir	11	suppressed
Primidone	Primidone	11	suppressed
Sure Comfort	Syring-Needl,disp,insul,0.3 Ml	11	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error